165 related articles for article (PubMed ID: 27656911)
1. Palonosetron-5-HT
Price KL; Lillestol RK; Ulens C; Lummis SC
ACS Chem Neurosci; 2016 Dec; 7(12):1641-1646. PubMed ID: 27656911
[TBL] [Abstract][Full Text] [Related]
2. Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.
Del Cadia M; De Rienzo F; Weston DA; Thompson AJ; Menziani MC; Lummis SC
Bioorg Med Chem; 2013 Dec; 21(23):7523-8. PubMed ID: 24128813
[TBL] [Abstract][Full Text] [Related]
3. Agonists and antagonists induce different palonosetron dissociation rates in 5-HT₃A and 5-HT₃AB receptors.
Lummis SC; Thompson AJ
Neuropharmacology; 2013 Oct; 73():241-6. PubMed ID: 23747573
[TBL] [Abstract][Full Text] [Related]
4. Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.
Hothersall JD; Moffat C; Connolly CN
Br J Pharmacol; 2013 Jul; 169(6):1252-62. PubMed ID: 23581504
[TBL] [Abstract][Full Text] [Related]
5. Varenicline Interactions at the 5-HT3 Receptor Ligand Binding Site are Revealed by 5-HTBP.
Price KL; Lillestol RK; Ulens C; Lummis SC
ACS Chem Neurosci; 2015 Jul; 6(7):1151-7. PubMed ID: 25648658
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Pharmacological Evaluation of [
Mu L; Müller Herde A; Rüefli PM; Sladojevich F; Milicevic Sephton S; Krämer SD; Thompson AJ; Schibli R; Ametamey SM; Lochner M
ACS Chem Neurosci; 2016 Nov; 7(11):1552-1564. PubMed ID: 27571447
[TBL] [Abstract][Full Text] [Related]
7. The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor.
Zarkadas E; Zhang H; Cai W; Effantin G; Perot J; Neyton J; Chipot C; Schoehn G; Dehez F; Nury H
Structure; 2020 Oct; 28(10):1131-1140.e4. PubMed ID: 32726573
[TBL] [Abstract][Full Text] [Related]
8. Broad-spectrum antiemetic potential of the L-type calcium channel antagonist nifedipine and evidence for its additive antiemetic interaction with the 5-HT(3) receptor antagonist palonosetron in the least shrew (Cryptotis parva).
Darmani NA; Zhong W; Chebolu S; Vaezi M; Alkam T
Eur J Pharmacol; 2014 Jan; 722():2-12. PubMed ID: 24513517
[TBL] [Abstract][Full Text] [Related]
9. The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.
Rojas C; Li Y; Zhang J; Stathis M; Alt J; Thomas AG; Cantoreggi S; Sebastiani S; Pietra C; Slusher BS
J Pharmacol Exp Ther; 2010 Nov; 335(2):362-8. PubMed ID: 20724484
[TBL] [Abstract][Full Text] [Related]
10. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
Rojas C; Stathis M; Thomas AG; Massuda EB; Alt J; Zhang J; Rubenstein E; Sebastiani S; Cantoreggi S; Snyder SH; Slusher B
Anesth Analg; 2008 Aug; 107(2):469-78. PubMed ID: 18633025
[TBL] [Abstract][Full Text] [Related]
11. Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.
Navari RM
Expert Opin Pharmacother; 2014 Dec; 15(17):2599-608. PubMed ID: 25323946
[TBL] [Abstract][Full Text] [Related]
12. Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function.
Rojas C; Thomas AG; Alt J; Stathis M; Zhang J; Rubenstein EB; Sebastiani S; Cantoreggi S; Slusher BS
Eur J Pharmacol; 2010 Jan; 626(2-3):193-9. PubMed ID: 19836386
[TBL] [Abstract][Full Text] [Related]
13. The C and E subunits of the serotonin 5-HT
Yaakob NS; Nguyen DT; Exintaris B; Irving HR
Biomed Pharmacother; 2018 Jan; 97():1701-1709. PubMed ID: 29793334
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of ligand recognition in 5-HT3 receptors.
Kesters D; Thompson AJ; Brams M; van Elk R; Spurny R; Geitmann M; Villalgordo JM; Guskov A; Danielson UH; Lummis SC; Smit AB; Ulens C
EMBO Rep; 2013 Jan; 14(1):49-56. PubMed ID: 23196367
[TBL] [Abstract][Full Text] [Related]
15. 5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy.
Navari RM
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2738-46. PubMed ID: 25838122
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic action of 5-HT3 receptor antagonists targeting peritoneal macrophages in post-operative ileus.
Maehara T; Matsumoto K; Horiguchi K; Kondo M; Iino S; Horie S; Murata T; Tsubone H; Shimada S; Ozaki H; Hori M
Br J Pharmacol; 2015 Feb; 172(4):1136-47. PubMed ID: 25377620
[TBL] [Abstract][Full Text] [Related]
17. Netupitant and palonosetron trigger NK1 receptor internalization in NG108-15 cells.
Thomas AG; Stathis M; Rojas C; Slusher BS
Exp Brain Res; 2014 Aug; 232(8):2637-44. PubMed ID: 24969614
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects.
Stathis M; Pietra C; Rojas C; Slusher BS
Eur J Pharmacol; 2012 Aug; 689(1-3):25-30. PubMed ID: 22683863
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.
Trattnig SM; Harpsøe K; Thygesen SB; Rahr LM; Ahring PK; Balle T; Jensen AA
J Biol Chem; 2012 Jul; 287(30):25241-54. PubMed ID: 22589534
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.
Rojas C; Raje M; Tsukamoto T; Slusher BS
Eur J Pharmacol; 2014 Jan; 722():26-37. PubMed ID: 24184669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
